O'Shaughnessy Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

O'Shaughnessy Asset Management’s Portfolio EGRX Stock Details EGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,809	Closed	-$214K	–	1428
2022 Q2	$214K	Sell	4,809 -2,734	-36%	-$126K	﹤0.01%	1007
2022 Q1	$373K	Sell	7,543 -38	-0.5%	-$1.82K	0.01%	820
2021 Q4	$386K	Sell	7,581 -210	-3%	-$10.9K	0.01%	775
2021 Q3	$435K	Buy	7,791 +1,509	+24%	+$74.2K	0.01%	704
2021 Q2	$269K	Buy	6,282 +5,478	+681%	+$226K	0.01%	894
2021 Q1	$34K	Buy	+804	New	+$37.3K	﹤0.01%	1521
2020 Q4	–	Sell	-9,119	Closed	-$388K	–	2257
2020 Q3	$388K	Sell	9,119 -11	-0.1%	-$481	0.01%	508
2020 Q2	$439K	Buy	9,130 +11	+0.1%	+$549	0.01%	430
2020 Q1	$421K	Sell	9,119 -176	-2%	-$8.83K	0.01%	317
2019 Q4	$557K	Buy	+9,295	New	+$554K	0.01%	375
2019 Q1	–	Sell	-1,264	Closed	-$51K	–	1026
2018 Q4	$51K	Sell	1,264 -3,412	-73%	-$176K	﹤0.01%	708
2018 Q3	$324K	Buy	4,676 +192	+4%	+$14.6K	0.01%	451
2018 Q2	$339K	Sell	4,484 -87	-2%	-$5.47K	0.01%	410
2018 Q1	$241K	Buy	4,571 +4,555	+28,469%	+$265K	0.01%	481
2017 Q4	$1K	Buy	+16	New	+$890	﹤0.01%	900

Other funds holding EGRX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

O'Shaughnessy Asset Management's EGRX Position: Q3 2022 in Review

O'Shaughnessy Asset Management sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q3 2022, closing a stake of 4,809 shares — an estimated $214K sold.

O'Shaughnessy Asset Management first reported a position in EGRX in Q4 2017 and held it in 15 quarters. The position peaked at $557K in Q4 2019. 153 funds tracked by Wall St. Rank hold EGRX as of Q3 2022.

O'Shaughnessy Asset Management reported no remaining Eagle Pharmaceuticals, Inc. position as of Q3 2022 after selling out during the quarter.
O'Shaughnessy Asset Management sold 4,809 Eagle Pharmaceuticals, Inc. shares in Q3 2022, an estimated $214K.
O'Shaughnessy Asset Management first reported a position in Eagle Pharmaceuticals, Inc. in Q4 2017 and held it in 15 quarters.
O'Shaughnessy Asset Management's Eagle Pharmaceuticals, Inc. position peaked at $557K in Q4 2019.
153 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q3 2022.

Based on O'Shaughnessy Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.